3.22.0.1 html 211 495 1 false 71 0 false 12 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://c4therapeutics.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityDeficitParenthetical Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Consolidated Statements of Cash Flows Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100070 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://c4therapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 100080 - Disclosure - Nature of the Business and Basis of Presentation Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of the Business and Basis of Presentation Notes 9 false false R10.htm 100090 - Disclosure - Summary of Significant Accounting Policies Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 100100 - Disclosure - Fair Value Measurements Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 100110 - Disclosure - Marketable Securities Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 12 false false R13.htm 100120 - Disclosure - Property and Equipment Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment Notes 13 false false R14.htm 100130 - Disclosure - Leases Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeases Leases Notes 14 false false R15.htm 100140 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 100150 - Disclosure - Collaboration and License Agreements Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements Collaboration and License Agreements Notes 16 false false R17.htm 100160 - Disclosure - Long-term Debt and Warrant - Related Party Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLongTermDebtAndWarrantRelatedParty Long-term Debt and Warrant - Related Party Notes 17 false false R18.htm 100170 - Disclosure - Stockholders Equity Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockholdersEquity Stockholders Equity Notes 18 false false R19.htm 100180 - Disclosure - Stock-based Compensation Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensation Stock-based Compensation Notes 19 false false R20.htm 100190 - Disclosure - Income Taxes Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 20 false false R21.htm 100200 - Disclosure - Loss Per Share Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShare Loss Per Share Notes 21 false false R22.htm 100210 - Disclosure - Defined Contribution Plan Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureDefinedContributionPlan Defined Contribution Plan Notes 22 false false R23.htm 100220 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 24 false false R25.htm 100240 - Disclosure - Fair Value Measurements (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurements 25 false false R26.htm 100250 - Disclosure - Marketable Securities (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureMarketableSecurities 26 false false R27.htm 100260 - Disclosure - Property and Equipment (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosurePropertyAndEquipment 27 false false R28.htm 100270 - Disclosure - Leases (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeases 28 false false R29.htm 100280 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 29 false false R30.htm 100290 - Disclosure - Collaboration and License Agreements (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsTables Collaboration and License Agreements (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreements 30 false false R31.htm 100300 - Disclosure - Long Term Debt and Warrant - Related Party (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLongTermDebtAndWarrantRelatedPartyTables Long Term Debt and Warrant - Related Party (Tables) Tables 31 false false R32.htm 100310 - Disclosure - Stock-based Compensation (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationTables Stock-based Compensation (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensation 32 false false R33.htm 100320 - Disclosure - Income Taxes (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxes 33 false false R34.htm 100330 - Disclosure - Loss Per Share (Tables) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShareTables Loss Per Share (Tables) Tables http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShare 34 false false R35.htm 100340 - Disclosure - Nature of the Business and Basis of Presentation - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentationAdditionalInformationDetails Nature of the Business and Basis of Presentation - Additional Information (Details) Details 35 false false R36.htm 100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 36 false false R37.htm 100360 - Disclosure - Summary of Significant Accounting Policies - Summary of Depreciation on Equipment Calculated Using Straight-Line Method Over Estimated Useful Lives of Assets (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationOnEquipmentCalculatedUsingStraightLineMethodOverEstimatedUsefulLivesOfAssetsDetails Summary of Significant Accounting Policies - Summary of Depreciation on Equipment Calculated Using Straight-Line Method Over Estimated Useful Lives of Assets (Details) Details 37 false false R38.htm 100380 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis (Details) Details 38 false false R39.htm 100390 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureMarketableSecuritiesSummaryOfMarketableSecuritiesDetails Marketable Securities - Summary of Marketable Securities (Details) Details 39 false false R40.htm 100400 - Disclosure - Marketable Securities - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails Marketable Securities - Additional Information (Details) Details 40 false false R41.htm 100410 - Disclosure - Property and Equipment - Summary of Property and Equipment (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetails Property and Equipment - Summary of Property and Equipment (Details) Details 41 false false R42.htm 100420 - Disclosure - Property and Equipment - Summary of Depreciation Expense Related to Property and Equipment (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfDepreciationExpenseRelatedToPropertyAndEquipmentDetails Property and Equipment - Summary of Depreciation Expense Related to Property and Equipment (Details) Details 42 false false R43.htm 100430 - Disclosure - Leases - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 43 false false R44.htm 100440 - Disclosure - Leases - Summary of Lease Costs (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfLeaseCostsDetails Leases - Summary of Lease Costs (Details) Details 44 false false R45.htm 100450 - Disclosure - Leases - Summary of Lease Term and Incremental Borrowing Rate Applied In Arriving at Lease Liability (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityDetails Leases - Summary of Lease Term and Incremental Borrowing Rate Applied In Arriving at Lease Liability (Details) Details 45 false false R46.htm 100460 - Disclosure - Leases - Undiscounted Minimum Future Lease Payments Under Non-cancelable Leases (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLeasesUndiscountedMinimumFutureLeasePaymentsUnderNonCancelableLeasesDetails Leases - Undiscounted Minimum Future Lease Payments Under Non-cancelable Leases (Details) Details 46 false false R47.htm 100480 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Details) Details 47 false false R48.htm 100490 - Disclosure - Collaboration and License Agreements - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsAdditionalInformationDetails Collaboration and License Agreements - Additional Information (Details) Details 48 false false R49.htm 100500 - Disclosure - Collaboration and License Agreements - Summary of Allocation of Total Transaction price and Unsatisfied Transaction Price (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsSummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceDetails Collaboration and License Agreements - Summary of Allocation of Total Transaction price and Unsatisfied Transaction Price (Details) Details 49 false false R50.htm 100510 - Disclosure - Collaboration and License Agreements - Schedule of Revenue from Collaboration Agreements (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsScheduleOfRevenueFromCollaborationAgreementsDetails Collaboration and License Agreements - Schedule of Revenue from Collaboration Agreements (Details) Details 50 false false R51.htm 100520 - Disclosure - Collaboration and License Agreements - Schedule of Financial Information Related to Collaboration and License Agreements (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsScheduleOfFinancialInformationRelatedToCollaborationAndLicenseAgreementsDetails Collaboration and License Agreements - Schedule of Financial Information Related to Collaboration and License Agreements (Details) Details 51 false false R52.htm 100530 - Disclosure - Collaboration and License Agreements - Schedule of Other Financial Information Related to Collaboration and License Agreements (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureCollaborationAndLicenseAgreementsScheduleOfOtherFinancialInformationRelatedToCollaborationAndLicenseAgreementsDetails Collaboration and License Agreements - Schedule of Other Financial Information Related to Collaboration and License Agreements (Details) Details 52 false false R53.htm 100540 - Disclosure - Long-term Debt and Warrant - Related Party - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLongTermDebtAndWarrantRelatedPartyAdditionalInformationDetails Long-term Debt and Warrant - Related Party - Additional Information (Details) Details 53 false false R54.htm 100550 - Disclosure - Long-term Debt and Warrant - Related Party - Summary of Anticipated Future Minimum Payments of Long-term Debt (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLongTermDebtAndWarrantRelatedPartySummaryOfAnticipatedFutureMinimumPaymentsOfLongTermDebtDetails Long-term Debt and Warrant - Related Party - Summary of Anticipated Future Minimum Payments of Long-term Debt (Details) Details 54 false false R55.htm 100560 - Disclosure - Stockholder's Equity - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockholderSEquityAdditionalInformationDetails Stockholder's Equity - Additional Information (Details) Details 55 false false R56.htm 100570 - Disclosure - Stock-based Compensation - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails Stock-based Compensation - Additional Information (Details) Details 56 false false R57.htm 100580 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationExpenseDetails Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) Details 57 false false R58.htm 100590 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails Stock-based Compensation - Summary of Stock Option Activity (Details) Details 58 false false R59.htm 100600 - Disclosure - Stock-based Compensation - Summary of Other Information Related to the Option Activity (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOtherInformationRelatedToOptionActivityDetails Stock-based Compensation - Summary of Other Information Related to the Option Activity (Details) Details 59 false false R60.htm 100610 - Disclosure - Stock-based Compensation - Summary of Significant Assumptions Used in the Black-scholes Pricing Model to Determine the Fair Value of Stock Options Granted (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSignificantAssumptionsUsedInBlackScholesPricingModelToDetermineFairValueOfStockOptionsGrantedDetails Stock-based Compensation - Summary of Significant Assumptions Used in the Black-scholes Pricing Model to Determine the Fair Value of Stock Options Granted (Details) Details 60 false false R61.htm 100620 - Disclosure - Income Taxes - Summary of Income Tax (Benefit) Expense (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxBenefitExpenseDetails Income Taxes - Summary of Income Tax (Benefit) Expense (Details) Details 61 false false R62.htm 100630 - Disclosure - Income Taxes - Summary of Reconciliation of Expected Income Tax (Benefit) Expense (Benefit) (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfExpectedIncomeTaxBenefitExpenseBenefitDetails Income Taxes - Summary of Reconciliation of Expected Income Tax (Benefit) Expense (Benefit) (Details) Details 62 false false R63.htm 100640 - Disclosure - Income Taxes - Summary of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfSignificantComponentsOfDeferredTaxAssetsAndDeferredTaxLiabilitiesDetails Income Taxes - Summary of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities (Details) Details 63 false false R64.htm 100650 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 64 false false R65.htm 100660 - Disclosure - Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShareScheduleOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails Loss Per Share - Schedule of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) Details 65 false false R66.htm 100670 - Disclosure - Loss Per Share - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShareAdditionalInformationDetails Loss Per Share - Additional Information (Details) Details 66 false false R67.htm 100680 - Disclosure - Loss Per Share - Schedule of Basic and Diluted Loss Per Share (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureLossPerShareScheduleOfBasicAndDilutedLossPerShareDetails Loss Per Share - Schedule of Basic and Diluted Loss Per Share (Details) Details 67 false false R68.htm 100690 - Disclosure - Defined Contribution Plan - Additional Information (Details) Sheet http://c4therapeutics.com/20211231/taxonomy/role/DisclosureDefinedContributionPlanAdditionalInformationDetails Defined Contribution Plan - Additional Information (Details) Details 68 false false All Reports Book All Reports cccc-10k_20211231.htm cccc-20211231.xsd cccc-20211231_cal.xml cccc-20211231_def.xml cccc-20211231_lab.xml cccc-20211231_pre.xml cccc-ex211_11.htm cccc-ex231_10.htm cccc-ex311_6.htm cccc-ex312_13.htm cccc-ex321_14.htm cccc-ex322_7.htm gn400xqwxb5u000001.jpg gn400xqwxb5u000002.jpg gn400xqwxb5u000003.jpg gn400xqwxb5u000004.jpg gn400xqwxb5u000005.jpg gn400xqwxb5u000006.jpg gn400xqwxb5u000007.jpg gn400xqwxb5u000008.jpg gn400xqwxb5u000009.jpg gn400xqwxb5u000010.jpg gn400xqwxb5u000011.jpg gn400xqwxb5u000012.jpg gn400xqwxb5u000013.jpg gn400xqwxb5u000014.jpg gn400xqwxb5u000015.jpg gn400xqwxb5u000016.jpg gn400xqwxb5u000017.jpg gn400xqwxb5u000018.jpg gn400xqwxb5u000019.jpg gn400xqwxb5u000020.jpg gn400xqwxb5u000021.jpg gn400xqwxb5u000022.jpg gn400xqwxb5u000023.jpg gn400xqwxb5u000024.jpg gn400xqwxb5u000025.jpg gn400xqwxb5u000026.jpg gn400xqwxb5u000027.jpg gn400xqwxb5u000028.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true